Silk Road Medical, Inc Appoints Rick Anderson as a Member of the Board
October 01, 2020 at 09:08 pm
Share
Silk Road Medical, Inc, on September 29, 2020, announced that its Board of Directors appointed Rick Anderson as a member of the Board, effective October 1, 2020, to serve as a Class I director, with a term expiring at the Company’s annual meeting of stockholders in 2023. Mr. Anderson has served as the Chairman and Managing Director of Revival Healthcare Capital, since January 2018. From September 2018 to October 2019, Mr. Anderson served as Chief Executive Officer and Chairman of the board of directors of ConvaTec Group Plc. From 2008 to January 2018, Mr. Anderson served as a Managing Director at PTV Healthcare Capital. Since October 2013, Mr. Anderson has served as a member of the board of directors of Apollo Endosurgery Inc.
Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.
SILK ROAD MEDICAL, INC 
